BonkDAO reports US$20M treasury theft
Bonk (CRYPTO:BONK) developer BonkDAO said attackers removed about US$20 million of BONK tokens from its Solana-based treasury through what the project described as a malicious governance proposal.

Jon is a former international magazine editor with a strong background in business publications (print and digital) in the Middle East and Australia.
Bonk (CRYPTO:BONK) developer BonkDAO said attackers removed about US$20 million of BONK tokens from its Solana-based treasury through what the project described as a malicious governance proposal.
A liquidity provider on Hyperliquid (CRYPTO:HYPE) lost about US$12,300 after approving a fraudulent wallet transaction that allowed an attacker to seize a tokenised HyperSwap liquidity position within 84 seconds.
New Zealand's AFT Pharmaceuticals (ASX:AFP) achieved sales growth in the first quarter of 2027.
Lockheed Martin (NYSE:LMT) has signed a definitive agreement to acquire Ultra Maritime, a specialist in undersea and anti-submarine warfare systems, in a transaction valued at $3.45 billion.
Innovative Eyewear (NASDAQ:LUCY) reported preliminary unaudited net sales of approximately $0.99 million for Q2 2026, representing a year-over-year increase of about 71%.
Ionis Pharmaceuticals (NASDAQ:IONS) announced it completed patient enrollment in the pivotal pediatric cohort of its global Phase 3 REVEAL clinical study evaluating its investigational RNA-targeted medicine, obudanersen.
AEVEX (NYSE:AVEX) announced it secured a $17.5 million follow-on defense contract under its Global Solutions business segment to continue delivering critical intelligence services.
Kosmos Energy (NYSE:KOS) reported strong operational progress in the first half of 2026, driven by higher production from its Jubilee field in Ghana and steady LNG performance in Mauritania and Senegal.
Nigel Farage, leader of Reform UK, rejected allegations that he improperly accepted undisclosed gifts from George Cottrell, a crypto-linked businessman convicted of wire fraud in the United States.
Clinical-stage company Syntara (ASX:SNT) announced that 20 of 30 patients recorded lower brain inflammation from baseline.